Searchable abstracts of presentations at key conferences in endocrinology

ea0050p050 | Bone and Calcium | SFEBES2017

Discontinuation of denosumab–real world experience from a single centre

Venkataraman Hema , Dar Shuja , Hiwot Tarek , Criseno Sherwin , Hassan-Smith Zaki , Gittoes Neil

There is concern about rapid reduction in bone mineral density (BMD) and early rebound vertebral fractures following discontinuation of denosumab. Our aim was to review local experience of discontinuation of denosumab, changes in BMD and fractures in patients with osteoporosis.Methods: A retrospective analysis was conducted for patients who discontinued denosumab between March 2011 & June 2016. Denosumab withdrawal(DW) was defi...

ea0050p050 | Bone and Calcium | SFEBES2017

Discontinuation of denosumab–real world experience from a single centre

Venkataraman Hema , Dar Shuja , Hiwot Tarek , Criseno Sherwin , Hassan-Smith Zaki , Gittoes Neil

There is concern about rapid reduction in bone mineral density (BMD) and early rebound vertebral fractures following discontinuation of denosumab. Our aim was to review local experience of discontinuation of denosumab, changes in BMD and fractures in patients with osteoporosis.Methods: A retrospective analysis was conducted for patients who discontinued denosumab between March 2011 & June 2016. Denosumab withdrawal(DW) was defi...